Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis by Rauch, Philipp J. et al.
 
Rapid monocyte kinetics in acute myocardial infarction are
sustained by extramedullary monocytopoiesis
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Leuschner, Florian, Philipp J. Rauch, Takuya Ueno, Rostic
Gorbatov, Brett Marinelli, Won Woo Lee, Partha Dutta, Ying Wei,
Clinton Robbins, Yoshiko Iwamoto, Brena Sena, Aleksey
Chudnovskiy, Peter Panizzi, Edmund Keliher, John M. Higgins,
Peter Libby, Michael A. Moskowitz, Mikael J. Pittet, Filip K.
Swirski, Ralph Weissleder, and Matthias Nahrendorf. 2012. Rapid
monocyte kinetics in acute myocardial infarction are sustained by
extramedullary monocytopoiesis. The Journal of Experimental
Medicine 209(1): 123-137.
Published Version doi:10.1084/jem.20111009
Accessed February 19, 2015 10:48:02 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10436858
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAArticle
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 209 No. 1  123-137
www.jem.org/cgi/doi/10.1084/jem.20111009
123
Monocytes (Mo) and the macrophages (M) to 
which they give rise are key effectors of immune 
homeostasis and response to injury. Virtually all 
disease areas with high socioeconomic impact, 
including  cancer,  infection,  and  autoimmune 
and cardiovascular diseases, share similarities in 
engagement of the innate immune system. Often, 
these cells participate integrally in defense and 
tissue repair mechanisms, yet aberrant Mo/M 
function, as can occur in atherosclerosis and   
cancer, may instead aggravate disease. Hence, 
Mo/M are emerging therapeutic targets in the 
multitude of disorders that involve inflammation 
(Shimura et al., 2000; Libby, 2002; Luo et al., 
2006; Moskowitz et al., 2010).
Our knowledge of the mononuclear phago-
cyte system (MPS) has expanded rapidly (Gordon 
and Taylor, 2005; Liu et al., 2009; Geissmann 
et al., 2010). Today, we know that Mo arise from 
hematopoietic stem cells (HSCs) in the bone 
marrow,  pass  through  several  intermediate 
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Monocytes (Mo) and macrophages (M) are emerging therapeutic targets in malignant, cardio-
vascular, and autoimmune disorders. Targeting of Mo/M and their effector functions without 
compromising innate immunity’s critical defense mechanisms first requires addressing gaps in 
knowledge about the life cycle of these cells. Here we studied the source, tissue kinetics, and 
clearance of Mo/M in murine myocardial infarction, a model of acute inflammation after 
ischemic injury. We found that a) Mo tissue residence time was surprisingly short (20 h); b)  
Mo recruitment rates were consistently high even days after initiation of inflammation; c) the 
sustained need of newly made Mo was fostered by extramedullary monocytopoiesis in the 
spleen; d) splenic monocytopoiesis was regulated by IL-1; and e) the balance of cell recruit-
ment and local death shifted during resolution of inflammation. Depending on the experimental 
approach, we measured a 24 h Mo/M exit rate from infarct tissue between 5 and 13% of the 
tissue cell population. Exited cells were most numerous in the blood, liver, and spleen. Abroga-
tion of extramedullary monocytopoiesis proved deleterious for infarct healing and accelerated 
the evolution of heart failure. We also detected rapid Mo kinetics in mice with stroke. These 
findings expand our knowledge of Mo/M flux in acute inflammation and provide the ground-
work for novel anti-inflammatory strategies for treating heart failure.
© 2012 Leuschner et al.  This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six   
months after the publication date (see http://www.rupress.org/terms). After 
six months it is available under a Creative Commons License (Attribution–
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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turnover in the acute infarct (Nahrendorf et al., 2010b). Preclin-
ical (Panizzi et al., 2010) and clinical data (Tsujioka et al., 2009; 
Aoki et al., 2010) suggest that both insufficient and exuber-
ant recruitment of Mo/M are detrimental and may result in 
infarct expansion, left ventricular dilation, and heart failure.
By tracking Mo/M from birth to death, we discovered 
that cell flux is surprisingly fast; that the spleen is a major source 
of Mo beyond its initial reservoir function; that IL-1–triggered 
extramedullary emergency monocytopoiesis contributes sub-
stantially to the cell population in the infarct throughout the 
course of acute inflammation; and that Mo/M can exit in-
flamed infarct tissue and travel to lymphatic organs and the liver, 
although local cell death quantitatively dominated cell clear-
ance. Rapid Mo turnover and splenic Mo production were also 
found in mice with stroke, indicating that the infarct data can 
be generalized. These findings provide new information on 
mononuclear phagocyte kinetics during tissue injury, and solid-
ify our knowledge of Mo/M fate in acute inflammation.
RESULTS
Myeloid cells show fast turnover in inflamed tissue
Previous studies have addressed Mo behavior in circulation 
(van Furth and Cohn, 1968; Issekutz et al., 1981; Tacke et al., 
2006); however, less is known about these cell’s kinetics once 
they enter inflamed tissue (Helft et al., 2010). We therefore 
studied the turnover of Mo and Mo-derived M in MI, an 
injury that elicits a robust recruitment of Mo and presence of 
M for the first 1–2 wk (Frangogiannis et al., 2002).
Transplantation of infarcted hearts from CD45.2+ mice 
into CD45.1+ recipients, and flow cytometric analysis of di-
gested infarcts at different time points, allowed us to follow dy-
namic changes in the Mo population at the site of inflammation 
progenitor stages (granulocyte M progenitor [GMP] → M 
dendritic cell progenitor [MDP]; Geissmann et al., 2010) and 
migrate into the blood pool depending on the cytokine re-
ceptor CCR2 (Serbina and Pamer, 2006). This developmen-
tal program may take up to 1 wk (Johnston, 1988). Mo then 
circulate in blood and patrol the vasculature (Auffray et al., 
2007) for several days, before they are recruited to sites of in-
flammation where they can give rise to M and Mo-derived 
DCs (Mo-DCs; Cheong et al., 2010) and pursue a myriad of 
functions in tissue, including phagocytosis (Gordon and Taylor, 
2005), antigen presentation (Cheong et al., 2010), regulation 
of inflammation, and tissue repair (Geissmann et al., 2010; 
Robbins and Swirski, 2010). We have recently learned that a 
splenic reservoir dominates Mo supply in the first 24 h of 
acute inflammation (Swirski et al., 2009), and that the two 
major Mo subsets’ distinct timing follows specific cytokine 
cues (Nahrendorf et al., 2007b). Next, we must address criti-
cal knowledge gaps in our understanding of the myeloid cell 
life  cycle  before  we  can  therapeutically  harness  the  MPS 
without compromising the organism’s defense mechanisms.
In pursuit of such knowledge, we used mice with myocar-
dial infarction (MI) to fate-map Mo/M. Two considerations 
prompted the choice of this preparation, in which coronary   
artery ligation causes sterile tissue injury and ischemic necrosis 
of myocytes. First, coronary ligation in the mouse is a well-
studied model of tissue injury in an organ that can be trans-
planted for fate mapping experiments. Second, MI is the major 
cause of sudden death and the expanding world-wide heart fail-
ure epidemic (National Heart, Blood, and Lung Institute, 2009). 
Mo/M have emerged as key regulators of infarct healing; they 
execute essential functions such as removing dead tissue, 
promoting angiogenesis, and coordinating extracellular matrix 
Figure 1.  Monocyte infarct residence time after ischemia. Cell tissue kinetics were studied using flow cytometric analysis (FCM) of heart trans-
plants and BrdU pulse experiments. (A) Schematic set-up of the experiment (n = 16; experiment was performed four times). (B) Dot plots of FCM analysis 
showing the contribution of donor- and recipient-derived Mo in the infarcted heart at 6, 12, and 24 h after transplantation of the heart. (C) Number of 
Mo retrieved from digested infarcts on day 3 to 6 after MI by FCM. (D) Fitting of donor Mo (y-axis) over time (x-axis). Red circles indicate individual data, 
the gray line represents the fit described by the equation. (E) Flow cytometric DAPI staining of Mo in the infarct on day 3 after coronary ligation. (F) FCM 
analysis of the infarct 24 h after BrdU pulse. Dot plots are gated on Mo. (G) Fold-change in BrdU+ Mo and lineage+ cells in the heart after MI. Mean ± SEM  
(n = 3–10 per group, experiment was repeated twice). *, P < 0.05.JEM Vol. 209, No. 1 
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recruited to the site of inflammation after the time of BrdU in-
jection. Analysis of cells retrieved from 3-d-old infarcts revealed 
that 43 ± 4% of Mo in the infarct were BrdU+, and therefore   
at least 43% of the Mo were recruited within the preceding   
24 h (Fig. 1 F). It is worth noting that only 3% of lineage+ cells 
were BrdU+. During phase 2 of infarct healing (5 d after coro-
nary ligation), 35 ± 4% of Mo in the myocardium stained posi-
tively for BrdU. The absolute number of BrdU+ Mo in the 
heart increased >160-fold on day 3 after MI and by 98-fold   
on day 5 after MI (Fig. 1 G). In contrast, we did not detect an 
increase of lineage+ cells that incorporated BrdU (Fig. 1 G).   
Mo subset analysis revealed faster kinetics for inflammatory   
Ly-6Chigh when compared with Ly-6Clow Mo (Fig. 2). The 
BrdU data likely underestimate cell recruitment, as they do not 
include newly recruited cells that proliferated before the in-
jection of BrdU. This consideration may explain why the 
measurement of newly recruited Mo was 60% in the trans-
plant approach, but only 43% by BrdU labeling. Both methods 
reveal rapid cell kinetics in acute inflammation, with an aver-
age tissue residence time of 20 h.
Local death is the major, and egress a minor, contributor  
to cell clearance
The Mo/M population swells rapidly after onset of isch-
emia and starts to shrink 1 wk later during resolution of in-
flammation. In between, despite the persistent and massive 
cell recruitment and the short half-life in tissue described 
above, the size of the population remains fairly constant 
(Nahrendorf et al., 2007b). As cell clearance should therefore 
(outlined in Fig. 1 A). Donor and recipient mice were geneti-
cally identical except for the surface marker CD45 on white 
blood cells. The heterotopic heart transplant used in our fate 
mapping  experiments  induces  a  brief  additional  ischemia; 
therefore, isograft transplantations of noninfarcted CD45.2+ 
hearts into CD45.1+ recipients served as controls. We found 
that the mean graft ischemia time during transplantation of 
15.1 ± 0.9 min resulted in the accumulation of 4 × 103 ± 103 
Mo per mg tissue in isograft controls, whereas the number of Mo 
on day 4 after MI was 5 × 104 per mg infarct tissue, an order 
of magnitude higher. These control experiments indicate that 
the transplantation procedure had relatively modest effects on 
cell kinetics.
Analysis at 6, 12, and 24 h after transplantation of in-
farcted hearts revealed a rapid decrease of donor-derived Mo 
in the infarct, and the number of Mo recruited from the re-
cipient increased at a much faster rate than expected. As soon 
as 6 h after transplantation, 20 ± 1% of the Mo in the infarct 
were newly recruited from the recipient mouse. This num-
ber increased to 40 ± 3% at 12 h. After 24 h, the majority   
(60 ± 0.5%) of Mo present in the infarct derived from the   
recipient (Fig. 1 B).
These data informed a mathematical model of MPS 
dynamics in MI. Absolute leukocyte counts in the infarct re-
main fairly stable from day 3–6 after MI (Fig. 1 C; Nahrendorf 
et al., 2007b). The total Mo count was thus assumed to be 
constant, and we estimated its turnover rate by fitting a math-
ematical function to the percentage of donor-derived Mo   
in the MI at different points in time (Fig. 1 D). We found 
that the size of the donor-derived population was well- 
approximated by a single exponential decay with a rate of 
5% per hour. A least-squares fit between this model and the 
data had an adjusted R2 value of >99%. The model sug-
gests that the rate of cellular turnover is roughly constant 
during this period of time after MI. This turnover rate cor-
responded to an average residence time of Mo in tissue of 
20 h (for a detailed description of the model see the Supple-
mental discussion).
We then used BrdU pulse-chase experiments to explore 
if these unexpectedly fast cell fluxes could be supported with 
a second, independent method. To this end, we injected 
mice with BrdU, which incorporates into proliferating DNA 
in place of thymidine. This method labels cells that divide   
after the BrdU pulse. Flow cytometric staining for BrdU, at 
24 h after the pulse, enumerated Mo that had either prolifer-
ated in the infarct or that were recruited from a circulating cell 
population  that  was  maintained  by  monocytopoiesis  else-
where. Cell cycle analysis showed that Mo in the infarcted 
myocardium were not in S or G2 phase (Fig. 1 E), indicating 
that there was no local proliferation. Another potential source 
for BrdU+ cells in the infarct could be the accumulation of   
upstream myeloid progenitor cells, which proliferate and give 
rise to Mo. However, we found an extremely low number of 
these cells in the infarct (17 ± 6 and 36 ± 4 MDPs in the entire 
infarct on days 3 and 6 after coronary ligation, respectively). 
We  therefore  concluded  that  all  BrdU+  Mo  were  newly   
Figure 2.  Kinetics of Mo subsets after MI. (A) FCM of BrdU pulse 
experiment in naive mice on day 3 after MI (B) and on day 5 after MI (C). 
Dot plots show Mo identified as CD11bhigh (CD90/B220/CD49b/NK1.1/Ly-
6G)low (F4/80/CD11c)low, including separation into subsets using Ly-6C. 
Mean ± SEM (n = 4–6 per group, experiment was repeated twice).126 Monocyte kinetics in acute inflammation | Leuschner et al.
exited CD45.2+ lineage CD11b+ cells in the entire host 
circulation. The highest number of cells was found in the 
liver (12,429 ± 4,693), followed by the draining lymph nodes 
(3,383 ± 3,176) and the spleen (885 ± 592; Fig. 3 A). In sum-
mary, only 5% of Mo/M present at the site of inflammation 
were encountered in remote organs 24 h after transplantation. 
Of note, only F4/80low cells were found to have exited, suggest-
ing that only undifferentiated Mo leave the site of inflammation.
It is possible that exited cells approach the end of their 
lives and are then rapidly eliminated by scavenging M. 
Fast clearance of exited cells–and the CD45 surface marker 
we relied on for detection–may have led to an underestima-
tion of the exit rate. We therefore conceived a second experi-
ment that used a nonbiodegradable cell label. Specifically, we 
derivatized a nanoparticle that distributes to infarct Mo/M 
with  the  slow-decaying  radioisotope  111Indium  via  the 
tight chelator diethylenetriaminepentaacetic acid (DTPA; 
111In-CLIO).  Previous  work  (Harisinghani  et  al.,  2003; 
match recruitment, we next investigated the relative con-
tribution of three alternatives: (1) Mo/M may exit the site 
of inflammation and reenter circulation, (2) they may die   
locally, or (3) both processes may contribute. In this study, 
we focused on lineage CD11b+ cells because only a small 
fraction of myeloid cells in the heart was CD11b (4.2 ± 0.7% 
cells were F4/80+ CD11b and 2.1 ± 0.2% were CD11c+ 
CD11b on day 3 after MI).
To investigate cell exit, we first used transplantation of   
infarcted hearts between mice with diverging CD45 leuko-
cyte surface markers. We transplanted hearts 3 d after MI 
and collected blood and tissue samples from various organs   
24 h later (Fig. 3 A). CD11b+ CD45.2+ donor cells, which 
were “transplanted” while residing in the infarcted heart, were 
detected  in  the  CD45.1+  host  circulation  and  destination   
tissues. Although we clearly encountered cell exit, the numbers 
were small. Assuming a mouse blood volume of 0.080 ml/g   
(Mitruka and Rawnsley, 1977), we enumerated 10,388 ± 3,006 
Figure 3.  Mo clearance. Cell exit and local death were studied as major contributors to cell clearance from the site of inflammation. (A) Bar graph 
shows number of exited CD45.2+ Mo in organs based on FCM; pie chart illustrates percentage of exited myeloid cells normalized to the number in the 
infarct (n = 5). (B) Left bar graph shows excited cell number in organs calculated using alternative scintillation data; pie chart illustrates the exit rate. The 
right bar graph reflects decay-corrected photon counts of the graft before and 24 h after heart transplantation. Experiment was done in duplicate, data 
are mean ± SEM. (C) Immunofluorescence of infarct tissue (DAPI, blue; TUNEL, green; CD11b, red). Pie charts indicate frequency of TUNEL signal in 
CD11b+ cells (arrows; n = 5 per group). (D) Analysis of cell death by DAPI FCM staining in the heart (n = 4 per group). (E) In vitro time lapse microscopy of 
representative splenic Mo to determine timing of cell death signals. Experiment was done in duplicates.JEM Vol. 209, No. 1 
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learned how many cells were dying at the time of sacrifice. 
Yet, comparison of death to recruitment rates requires calcula-
tion of how many cells die locally within 24 h, and thus con-
sideration of the duration of cell death. Previous work reported 
that apoptosis may take 30 min for fibroblasts (Evan et al., 
1992) and from 30 min to 2 h for cardiomyocytes (Guerra   
et al., 1999). Because timing had not been studied in Mo/M, 
we cultured splenic Mo/M for dynamic multispectral fluor-
escence microscopy. During imaging, the cell medium con-
tained fluorescently labeled Annexin V, a marker of early stage 
apoptosis, and propidium iodide (PI), which indicates late-stage 
cell death. We found numerous events of cell death in a 2-h 
time-lapse microscopy experiment. Fig. 3 E shows a represen-
tative cell, which was viable for the first 35 min of image   
acquisition. Annexin V staining of the membrane was de-
tected at 40 min. At this time point, no PI signal was present, 
but it was detected 10 min later and was accompanied by cell 
integrity destruction on bright field images. Analyzing 10 
fields of view, we found a mean delay of 11 ± 3 min from the 
onset of Annexin V signal (indicating a cell had entered apop-
tosis) to onset of PI signal and destruction of the cell on bright 
field images (indicating completion of the cell death program). 
The in vitro signal duration of 11 min likely indicates a limited 
phase  of  cell  death,  whereas  the  complete  process  of  pro-
grammed cell death may take longer in vivo (Spencer and 
Sorger, 2011). Nevertheless, these data provide useful informa-
tion on the duration of certain “death signals” and allowed us 
to calculate that >106 apoptotic events could occur in 24 h,   
using the measured apoptotic rate of 1.9%, 11 min of death sig-
nal, and a population of 0.7 × 106 Mo/M in the infarct. Over-
all, these results are consistent with a dominant contribution of 
local death to Mo/M clearance in acute inflammation.
The spleen supplies Mo throughout the duration  
of acute inflammation
The high rate of Mo recruitment beyond the initial surge   
after injury raised the question of the source of these cells. 
The splenic Mo reservoir contributes predominantly to the 
infarct  Mo/M  population  in  the  first  24  h  after  injury 
(Swirski et al., 2009; Leuschner et al., 2010). After BrdU in-
jection, we observed an increase of BrdU+ Mo in the spleen 
from 19 ± 4% in the steady state to 56 ± 4% on day 3 after 
MI and 47 ± 8% on day 5 after infarct surgery. We therefore 
hypothesized that the spleen continues to contribute cells   
beyond the first 24 h. We removed the spleen on day 5 after 
MI and studied the Mo/M population in the infarct 24 h 
later by flow cytometric enumeration. Surprisingly, even at 
this late time point, removal of the spleen drastically reduced 
the number of Mo in inflamed tissue (Fig. 4 A; 3.8 × 104 ± 
4 × 103 vs. 1.3 × 104 ± 2 × 103; P < 0.01). In bone marrow, 
Mo did not increase significantly, although Mo numbers 
in the blood mirrored the reduction in the heart (Fig. 4 A; 
3.4 × 105 ± 8 × 104 vs. 2 × 105 ± 2 × 104; P < 0.05). Intrigu-
ingly, the number of BrdU+ Mo in infarct tissue fell sig-
nificantly after splenectomy (Fig. 4 B; from 34 ± 5% to 18 ± 
7%; P < 0.05).
Weissleder et al., 2005; Devaraj et al., 2009; Swirski et al., 
2009; Panizzi et al., 2010) and own, unpublished data show 
that  these  nanoparticles  efficiently  label  Mo/M  and  are 
cleared from the intravascular/extracellular space 24 h after 
intravenous injection. Mice were injected with 111In-CLIO 
two days after MI (Fig. 3 B). We then waited 24 h to allow 
for sufficient uptake into Mo/M in the infarct. Next, the 
heart  containing  111In-CLIO  labeled  infarct  Mo/M  was 
transplanted into a recipient mouse. Before transplantation 
and after a 24 h period that allowed for exit of labeled cells, 
the heart was studied by scintillation counting. After cor-
rection for 111Indium decay, we calculated the reduction 
of 111In-CLIO signal in the graft, and by extension departure 
of Mo/M from the infarct. We found 46.9 × 105 ± 5.2 × 105 
gamma counts per heart before implantation and 36.6 × 105 ± 
3.4 × 105 counts per heart 24 h later (Fig. 3 B). We also mea-
sured radioactivity in blood and exiting cell’s potential 
destination organs. Assuming a Mo/M population size of   
7 × 105 in MI (Nahrendorf et al., 2007b) and using the activity 
at time of transplantation, we calculated a photon count per 
Mo/M value of 5.2, which we then used to estimate the 
number of exited cells in transplant recipient tissues (Fig. 3 B). 
We found that the liver and blood were the compartments 
with the highest numbers of exited Mo/M (22,903 ± 2711 
and 10,220 ± 2410, respectively), confirming the results ob-
tained with flow cytometric detection of CD45.2. Summing 
radioactivity measured in the transplant recipient, we calcu-
lated that 13% of Mo/M had exited the heart within 24 h. 
We thus concluded that while exit occurred, its contribution 
to Mo/M clearance from the site of acute inflammation 
was minor.
Recruited innate immune cells can undergo apoptosis in 
MI in rabbits (Takemura et al., 1998). We therefore studied 
the rate of local Mo/M death in acute inflammation. We 
co-stained hearts harvested from mice 3 and 6 d after MI for 
CD11b, a surface marker for myeloid cells, and terminal de-
oxynucleotidyltransferase-mediated  dUTP-biotin  nick  end 
labeling (TUNEL; Fig. 3 C). TUNEL staining in infarcts 
harvested from CX3CR1gfp/+ mice confirmed that TUNEL+ 
cells were Mo and not neutrophils (unpublished data). Quan-
tification revealed that 1.9 ± 0.1% of CD11b+ cells were also 
TUNEL+, and therefore were undergoing apoptosis. On 
day 6 after MI, when the Mo/M population begins to con-
tract, 4.5 ± 2.0% of Mo/M were TUNEL+ (Fig. 3 C, 
MI day 3 vs. MI day 6; P = 0.03).
To  evaluate  these  results  with  a  second,  independent 
method, we analyzed Mo/M retrieved from infarcts by 
flow cytometric staining for DAPI. On day 3 after MI, 1.5 ± 
0.6% of Mo/M were in sub–G-phase, indicating apoptosis 
(Darzynkiewicz et al., 1992). On day 6 after MI, 3.9 ± 1.4% 
showed a sub-G expression (MI day 3 vs. MI day 6; P = 0.04). 
Similar results were obtained by flow cytometric analysis of   
active caspase 3 (Fig. 3 D, MI day 3, 2.3 ± 0.42% versus day 6, 
4.5 ± 0.38%, P < 0.05), thus confirming these apoptotic rates.
Histological and flow cytometric staining for death markers 
provided us only with an instantaneous “snap shot,” i.e., we 128 Monocyte kinetics in acute inflammation | Leuschner et al.
splenic production of Mo. To test the latter hypothesis, 
we harvested splenocytes on day 6 after MI and assessed 
their colony-forming capacity. Using steady-state spleno-
cytes from mice without MI as controls, we performed a 
The spleen is a major site of Mo production after MI
The reduction of BrdU+ Mo in infarct tissue 24 h after 
splenectomy could be explained by fast transfer of newly 
generated cells from the bone marrow to the spleen or by 
Figure 5.  MI induces extramedullary monocytopoiesis in the spleen. (A) CFU assay of splenocytes from naive mice and from mice 6 d after MI 
(n = 3 per group, experiment performed twice). Top images show representative scans of the culture plate, bottom images show magnifications of colo-
nies. (right) Bar graph enumerates colonies in cultures. (B) Representative dot plots from spleen and enumeration of splenic MDPs. lin* indicates lineage 
for myeloid progenitor staining as described in the Materials and methods section (n = 6–9 per group from three independent experiments). (C) Cell cycle 
analysis for splenic MDPs in mice after MI (n = 3 per group from one experiment). (D) Adoptive transfer of GMPs on day 3 after MI. CD45.2+ cells were 
transferred into infarcted CD45.1+ mice, which were analyzed 3 d later. Dot plots show adoptively transferred precursors in the splenic pool and the in-
farcted myocardium (n = 6 from one experiment). (E) Ly-6Chigh and Ly-6Clow Mo in the spleen after MI. Mean ± SEM (n = 4–10 per group from 4 indepen-
dent experiments). *, P < 0.05.
Figure 4.  The spleen is a major source of Mo during acute inflammation. (A) Gate in dot plots of infarcted hearts shows myeloid cells on day 6 
after MI (SPX indicates splenectomy 24 h before analysis; Lin indicates staining for lineage markers). Bar graphs enumerate total number of Mo in the 
heart, bone marrow, and blood (n = 6–9 per group, from three independent experiments). (B) Histograms gated on Mo in the heart. Bar graph shows the 
total number of BrdU+ Mo. Mean ± SEM (n = 4–6 per group, experiment performed twice). *, P < 0.05.JEM Vol. 209, No. 1 
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adoptive transfer of 105 CD45.2+ myeloid progenitors, we 
found 27,306 ± 2,841 transfer-derived Mo in the spleens   
and 16,850 ± 2,080 in the infarcts of CD45.1+ recipient 
mice.  Longitudinal  assessment  of  Mo  numbers  in  the 
spleen from day 1 to 10 after MI revealed a rapid refilling 
of the splenic Mo reservoir, which was replenished after 6 d 
(Fig. 5 E). Collectively, these findings suggest that splenic 
progenitor cells contribute importantly to the supply chain 
for Mo in acute inflammation and generate Mo that refill 
the splenic reservoir.
These newly described cell kinetics during acute inflam-
mation are summarized in a model, in which we begin to 
describe the system-wide monocytic cell flux by addressing 
temporal and spatial aspects of the inflammatory response to 
injury (Fig. 6).
Serial in vivo imaging reveals a key function for the spleen 
in infarct healing
To explore the relevance of splenic monocytopoiesis for left 
ventricular remodeling and the evolution of heart failure, we 
designed a longitudinal imaging trial investigating the effects   
of spleen removal. Mice received permanent coronary artery 
ligation and were (a) followed up without further interven-
tion, (b) splenectomized on the day of infarction, or (c) sple-
nectomized 3 d after MI. On day 1 after MI, mice were 
evaluated by cardiac MRI. Initially, there were no significant 
differences between groups regarding 
either left ventricular ejection fraction 
or infarct size (Fig. 7).
In the same mice, we used nonin-
vasive molecular imaging to map heal-
ing biomarkers related to MPS tissue 
functions. Phagocytic cells (CLIO- 
633), proteolysis (Prosense-750), and 
angiogenesis (IntegriSense-800) were 
quantified  with  multispectral  fluores-
cence molecular tomography (FMT)-
computed  tomography  (CT)  after 
co-injection of three molecular imag-
ing probes (Nahrendorf et al., 2009a). 
FMT-CT imaging on day 5 after MI 
showed that removal of the spleen re-
sulted  in  reduced  accumulation  of 
CLIO-AF633,  a  nanoparticle  targeted 
to Mo/M (Nahrendorf et al., 2007a), 
in the infarct (Fig. 7). These data indi-
cated reduced accumulation of phago-
cytic cells in the heart. Interestingly, 
CFU assay in medium with growth factors that promote 
myeloid colony formation, and found a sevenfold increase 
in CFU after MI (Fig. 5 A).
Encouraged by these data, we next defined the myelopoi-
etic activity in the post-MI spleen more precisely. The most 
differentiated clonogenic precursor that can still give rise to 
Mo is the M/dendritic cell precursor (MDP), which is 
defined by expression of CD115 (CSF1-R) and CD117 
(c-kit) within the Linlow IL-7R– Sca-1– population (Fogg   
et al., 2006; Auffray et al., 2009). FACS enumeration re-
vealed a dramatic rise in splenic MDP numbers (Fig. 5 B), 
which started to increase 3 d after injury and peaked at 6 d   
after MI. The 24-fold increase in MDP was more pronounced 
than the increase in total myelopoietic activity, suggesting that 
splenic myelopoiesis after MI slants toward Mo production.
We  then  asked  whether  the  splenic  MDP  population 
could give rise to their progeny in vivo. Cell cycle analysis 
using DAPI staining revealed that one third of the MDP pop-
ulation was in the S or G2 phase of the cell cycle (Fig. 5 C), 
indicating active proliferation. Fate mapping experiments in-
volving  adoptive  transfer  of  granulocyte-M  progenitors 
(GMP, a population upstream of MDP in the develop-
ment of Mo; Auffray et al., 2009) into mice with MI showed 
that the adoptively transferred precursors effectively contrib-
uted Mo to the splenic pool, which mobilized to the site 
of inflammation, the healing myocardium (Fig. 5 D). 3 d after 
Figure 6.  Current systemic MPS flux 
model in subacute MI in the mouse. The 
model was populated with numbers and rates 
obtained in mice with coronary ligation and is 
a first attempt at a more systematic visualiza-
tion of system-wide cell kinetics in acute 
inflammation.130 Monocyte kinetics in acute inflammation | Leuschner et al.
to analyze collagen deposition in the hearts after MI: Mas-
son trichrome, picrosirius red staining, and immunoreactive 
staining for collagen I. All three showed reduced extracel-
lular matrix and compromised healing of infarcts in mice 
without spleens (Fig. 8). As seen in the imaging trial, even late 
removal of the spleen, a site of monocytopoiesis, led to dete-
riorated wound healing.
Rapid Mo kinetics, local death, and splenic Mo  
production in stroke
To evaluate if our findings are applicable to other causes of 
acute inflammation, we examined Mo kinetics in mice with 
stroke.  BrdU  pulse-chase  experiments  revealed  rapid  Mo 
turnover kinetics in the brain after occlusion of the middle 
cerebral artery. On day 2 after stroke, 28 ± 6% of all CD11b+ 
lineage cells in the brain were BrdU+ after receiving BrdU 
pulses 12 and 24 h before tissue harvest (Fig. 9 A). This 
CD11b+ lineage population includes resident microglia 
(Graeber, 2010), whereas inflammatory Ly-6Chigh Mo are 
not  found  in  brain  tissue  of  healthy  mice.  Specifically, 
CD11b+ microglia are Ly-6Clow (Duncan and Miller, 2011). 
Analyzing the turnover of inflammatory Ly-6Chigh Mo in the 
ischemic brain, we found comparable numbers to those seen 
in myocardial infarcts: 44 ± 9% of Ly-6Chigh Mo were BrdU+ 
24 h after BrdU pulses (Fig. 9 B). These data imply that 
this reduced uptake was observed regardless of the timing   
of spleen removal. Prosense-750 activation also fell in sple-
nectomized mice (Fig. 7), indicating lower proteolytic activ-
ity in infarcts (Nahrendorf et al., 2007a). The third imaging 
channel measured expression of the integrin v3, a bio-
marker expressed by endothelial cells in neovessels and by   
fibroblasts (Nahrendorf et al., 2007a). The concentration of 
IntegriSense-800 in the infarct declined after splenectomy at 
either time point (Fig. 7).
Finally, we reimaged mice by cardiac MRI 3 wk after 
MI. We found that splenectomy at either time point signifi-
cantly impaired left ventricular ejection fraction and re-
sulted  in  a  thinner  scar,  signifying  infarct  expansion  and 
accelerated left ventricular remodeling (Fig. 7). Collectively, 
these data show that removal of the spleen reduced MPS-
mediated healing biomarkers and accelerated the evolution 
of heart failure.
To relate the imaging findings to histological assess-
ment of tissue healing, we evaluated additional cohorts   
of mice on day 7 after MI (Fig. 8). The removal of the 
spleen, either at the time of infarction or 3 d later, reduced 
the numbers of cells expressing CD11b and MAC-3. Neo-
vascularization was impaired in mice that had been sple-
nectomized, as indicated by a reduced number of CD31+ 
microvessels (Fig. 8). Three different methods were used 
Figure 7.  Serial in vivo imaging reveals key function of splenic Mo/M in infarct healing. Study groups: MI and no SPX (top row), MI and SPX 
on d0 (middle), and MI and SPX on d3 after MI (bottom). Three-channel FMT-CT was done on day 5 after MI. Bar graphs on the bottom show fluorescence 
signal in the infarct in respective channels. MR images from day 1 (inset) and day 21 (full size) are shown on the right, with bar graphs on the bottom. 
Arrows indicate gadolinium-DTPA enhanced infarct. Mean ± SEM (n = 8–12 per group from two experiments). *, P < 0.05.JEM Vol. 209, No. 1 
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1 × 104 in IL-1R/ (P = 0.001; Fig. 10 C). Although in-
farcts from WT mice contained 3.7 × 104 Mo per mg tissue, 
infarcted hearts from IL-1R/ recruited only 2.0 × 104 Mo 
(P = 0.01; Fig. 10 C). This decrease paralleled our estimation 
of what the spleen contributes to the Mo population in the 
infarct (Fig. 4).
Mo flux rates are not only high in MI but also in other 
acutely ischemic tissues.
Next, we assessed local death rates of Mo in ischemic 
brain tissue. We found that 2 ± 0.2% of Mo were caspase-3+ 
on day 2 after induction of stroke. On day 4, the percentage 
of Mo undergoing apoptosis was 6 ± 0.5%, comparable to 
the data in MI.
We also enumerated Mo in the spleen in mice with 
stroke. Their number was reduced by 48% on day 2 after in-
jury (P = 0.03; Fig. 9 C), indicating that the splenic Mo res-
ervoir supplied the injured brain tissue. Finally, we assessed 
splenic monocytopoiesis 10 d after stroke by enumeration of 
MDPs. We found that numbers of splenic MDPs increased 
eightfold (P < 0.01; Fig. 9 D) and concluded that the spleen 
is a site of Mo production after stroke, comparable to the sit-
uation after MI.
IL-1 signaling and splenic monocytopoiesis
To identify pathways involved in extramedullary monocyto-
poiesis after MI, we screened spleen mRNA levels after MI 
for a variety of candidate cytokines and growth factors, in-
cluding  IL-1,  IL-1,  TNF,  IL-6,  CXCL12,  VCAM-1, 
ICAM, M-CSF, GM-CSF, and G-CSF. Interestingly, we 
only found a marked sustained increase in the expression of 
IL-1 (Fig. 10 A and not depicted). An ELISA confirmed a 
significant increase of IL-1 protein in the spleen on day 6 
after MI (Fig. 10 A).
We next induced MI in mice lacking the IL-1 receptor 
(IL-1R/) and assessed splenic monocytopoiesis 6 d there-
after. The number of CFUs was markedly reduced in IL-1R/ 
spleens (Fig. 10 B), and MDPs were reduced by 67% in   
IL-1R/ mice when compared with WT (2.3 × 103 vs. 6.1 × 
103; P = 0.005; Fig. 10 C). In addition, the number of newly 
made BrdU+ Mo was reduced from 2.9 × 104 in WT mice to 
Figure 8.  Histological biomarkers of infarct healing after splenectomy. Experimental groups: MI and no SPX (top row), MI and SPX on d0 (middle), 
and MI and SPX on d3 after MI (bottom). IHC staining for myeloid cells (CD11b), M (MAC-3), neo-vascularization (CD31), and collagen deposition (Masson 
trichrome, picrosirius red [PSR], and collagen I). ROI, region of interest. Mean ± SEM (n = 5 per group from one experiment). *, P < 0.05.
Figure 9.  Rapid Mo kinetics and supply of splenic Mo in stroke.  
(A) Dot plots from brain tissue gated on CD11b+ and lineage cells 24 h 
after BrdU pulse. Mean ± SEM (n = 4–5 per group; P < 0.05 stroke vs. no 
stroke). (B) Pie chart illustrates turnover of Ly-6Chigh Mo in the brain on 
day 2 after stroke. (C) Number of Mo in the spleen after stroke. Dot plots 
are gated on CD11b+ lin cells and compare naive control mice to mice 2 d 
after stroke. Bar graph shows total Mo in the spleen. Mean ± SEM  
(*, P < 0.05; n = 4–5 per group from one experiment). (D) Increased MDP 
on day 10 after stroke in the spleen. Mean ± SEM (*, P < 0.05, n = 4–5 per 
group from one experiment).132 Monocyte kinetics in acute inflammation | Leuschner et al.
the population was replaced by a new generation of cells, 
even days after initiation of inflammation. Collectively, these 
findings allow one to construct simple models of in vivo cell 
kinetics (Fig. 6).
The spleen furnished most of this constant stream of Mo. 
Recent work found that the spleen contains a readily mobi-
lizable emergency reservoir of Mo that exhausts in the first 
hours after injury (Swirski et al., 2009). We now report that 
the spleen provides cells continuously to satisfy the persistently 
high demand at the site of inflammation. Surgical removal of 
the spleen several days after coronary ligation substantially re-
duced the number of Mo recruited to the infarct and led to 
impaired wound healing and heart failure. Interestingly, we 
found a robust expansion of myeloid progenitor cells (MDP) 
in the spleen, indicating that the organ hosted niches for extra-
medullary emergency monocytopoiesis. Adoptive transfer of 
upstream progenitors (GMP) resulted in splenic seeding, and 
the transferred cells gave rise to splenic Mo, which then trav-
eled to the site of inflammation. (We do not yet know how 
many of these Mo differentiate into M once they have en-
tered the infarct; we did not pursue this question because of 
the technical limitations of fate mapping methods, i.e., Mo 
activation and initiation of differentiation during cell sorting 
for adoptive transfer.) The initial loss of splenic Mo during the 
onset of injury, when the spleen’s reservoir departs, recovers 
quickly, as the cell numbers in the spleen reached preinjury 
To investigate if the reduction of splenic monocytopoi-
esis is caused by the absence of the IL-1R on myeloid pro-
genitors, we adoptively transferred FACS-sorted GMPs from 
either WT or IL-1R/ mice (both CD45.2+) into CD45.1+ 
mice, 1 d after MI (outlined in Fig. 10 D). Flow cytometric 
analysis 5 d later revealed that even though each recipient 
had received the same number of progenitor cells (105), 
CD45.2+  progeny  was  significantly  reduced  in  mice  that 
were injected with IL-1R/ GMPs (2,123 ± 463 Mo after 
transfer of IL-1R/ GMPs vs. 7,907 ± 1,436 WT; P = 0.008; 
Fig. 10, E and F). These results indicate that direct IL-1 signal-
ing on myeloid progenitors controls splenic monocytopoiesis.
DISCUSSION
Our knowledge of innate immune cell function has rapidly 
expanded in the last decade, but cell kinetics, especially turn-
over rates in inflamed tissue, remain incompletely understood. 
Conventional wisdom suggested that a large population of 
Mo is recruited at initiation of acute inflammation, that these 
cells pursue their specific function for the duration of the 
acute inflammatory process, and that their presence wanes 
when inflammation resolves. This study used an acute inflam-
matory state in the heart to fate map Mo/M and to deter-
mine their turnover rates in tissue. Contrary to preconception, 
we found extremely rapid kinetics. Mo spent a mean of 20 h 
at the site of inflammation, and within 24 h the majority of 
Figure 10.  IL-1 is a key cytokine for splenic monocytopoiesis. (A) rtPCR of IL-1 mRNA expression in the spleen throughout the first week after 
MI (n = 6–7 per group; *, P < 0.05). IL-1 protein by ELISA in the spleen on day 6 after MI (n = 4 per group; *, P < 0.05). (B) Cultured spleen cells from WT 
and IL-1R/ mice colony forming capacity on day 6 after MI. Experiment was done in duplicates. (C) Enumeration after FCM analysis on day 6 after MI of 
splenic MDPs (left), BrdU+ Mo in the spleen (middle), and in the heart (right) of IL-1R/ mice compared with WT. Mean ± SEM (n = 5 per group; *, P < 
0.05). (D) Setup of the experiment: Adoptive transfer of CD45.2+ GMPs into infarcted CD45.1+ mice 1 d after MI. Analysis was performed 5 d later, com-
paring the capacity of transferred cells to generate Mo in the presence (WT) or absence (IL-1/) of the IL-1R. (E) Dot plots from spleens are gated on Mo, 
identified as CD11b+, lineage, and CD11c. Mean percentage ± SEM (n = 4 recipients per group). (F) Enumeration of CD45.2+ Mo in the spleens of 
CD45.1+ recipients 6 d after MI and 5 d after adoptive transfer. Mean ± SEM (n = 4 per group; *, P < 0.05).JEM Vol. 209, No. 1 
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These new insights into the life cycle of Mo/M can 
guide identification of novel therapeutic strategies. Because 
the tissue residence time of Mo in acute inflammation is as 
short as 20 h in the mouse, and because continuous cell re-
cruitment occurs on a large scale, therapies that target cell 
production, for instance in the splenic niche, may produce 
favorable outcomes. Mo recruitment appears to be an attrac-
tive target beyond the first hours of injury. Manipulating the 
recruitment/death balance could induce resolution if inflam-
mation  lingers  and  threatens  to  compromise  tissue  repair. 
Notably, the reported cell kinetics apply to acute inflamma-
tion; further investigations should probe how chronic inflam-
matory processes differ.
The data were collected in a type of tissue injury with 
high  clinical  relevance.  Many  patients  with  myocardial 
ischemia likely suffer from exuberant or prolonged inflam-
mation, which may exacerbate injury or hinder swift repair 
(Maekawa et al., 2002; Nahrendorf et al., 2010b). Exagger-
ated infarct inflammation, a situation previously modeled in 
mice with atherosclerosis (Leuschner et al., 2010; Panizzi et al., 
2010) and frequently found in patients with atherosclerotic 
disease, impedes efficient infarct healing and promotes left 
ventricular dilation (Nahrendorf et al., 2010b). The current 
serial imaging data in WT mice with coronary ligation under-
line the role of the spleen in recovery after MI, with the 
limitation that splenectomy neutralizes a variety of immune 
cells that might affect the remodeling differently. In patients 
with acute MI, high Mo blood levels correlate inversely with 
ejection fraction (Tsujioka et al., 2009), which is a strong predic-
tor of mortality. Therefore, insight into infarct cell kinetics and 
the fate of Mo/M in MI provide a much needed foundation 
for developing novel therapy options in heart failure, a condition 
that afflicts 5 million patients in the United States and carries an 
annual mortality of up to 50% (Roger et al., 2011).
MATERIALS AND METHODS
Mouse models. MI was induced by permanent coronary ligation as de-
scribed previously (Leuschner et al., 2010). In brief, mice were anesthe-
tized  with  Isoflurane  (2%/2  liters  O2),  intubated,  and  ventilated  with   
an Inspira Advanced Safety Single Animal Pressure/Volume Controlled 
Ventilator (Harvard Apparatus). The chest wall was shaved, and left thora-
cotomy was performed in the fourth left intercostal space. The left ventri-
cle was visualized, and the left coronary artery was permanently ligated 
with monofilament nylon 8–0 sutures (Ethicon) at the site of its emergence 
from under the left atrium. The chest wall was closed with 7–0 nylon   
sutures and the skin was sealed with superglue.
Splenectomy was performed using Isoflurane anesthesia. The mouse’s 
abdominal cavity was opened, the spleen vessels were cauterized, and the 
spleen was carefully removed (Swirski et al., 2009).
Hearts were transplanted into the recipients’ peritoneal cavity by estab-
lishing an end-to-side anastomosis of the donor aorta to the recipient aorta 
and an end-to-side anastomosis of the donor pulmonary trunk to the inferior 
vena cava, as described previously (Swirski et al., 2010). The total operative 
time was in the range of 30–40 min. The ischemia time for the transplanted 
heart was 15.1 ± 0.9 min. If myocardial contractions were not palpated 
through the abdomen, the procedure was considered a surgical failure and 
the mouse was excluded from experiments. To create the same systemic im-
mune environment, we infarcted both graft donors and recipients.
levels in <1 wk. Mice with stroke experienced a similar depar-
ture of splenic Mo followed by increased progenitor activity. 
Collectively, these data position the spleen as a major site of 
inflammatory Mo production in acute inflammation.
We identified IL-1 as a signal for splenic Mo production 
after MI, in line with previous insight on the cytokine’s role in 
the expansion of progenitors (Brugger et al., 1993; McKinstry   
et al., 1997). In parallel to our findings in the spleen, IL-1 
also appears to regulate prenatal extramedullary hemato-
poiesis in the liver (Orelio et al., 2009). The cytokine’s expres-
sion increases in patients and rodents after MI (Balbay et al., 
2001; Li et al., 2006). Thus, although regulation of hemato-
poiesis relies on multifactorial mechanisms (Brugger et al., 
1993), these data point toward a key role for IL-1 in trig-
gering extramedullary monocytopoiesis after MI.
After the initial surge of Mo/M in the infarct, the over-
all size of the cell population at the inflammatory site remained 
stable for several days, despite ongoing large-scale recruit-
ment. Hence, we investigated what mechanism accounts 
for clearance of cells from the infarct. We found that the high 
recruitment  rates  were  matched  by  rapid  cell  death.  Fre-
quency and duration of apoptotic events suggested that death 
could clear as many cells from the infarct as were newly re-
cruited. Interestingly, we found that the frequency of apop-
totic Mo/M increased at later time points, from <2% on 
day 3 to >4% on day 6 after MI. At the same time, cell re-
cruitment decelerated from 43% BrdU+ cells on day 3 versus 
35% on day 5. These results indicate that the balance of cell 
recruitment and local cell death regulated the overall size   
of the Mo/M population. Death rates were higher and   
recruitment  slower  at  later  time  points;  therefore,  when 
apoptotic death exceeds recruitment, the cell population 
contracts and resolution of inflammation commences.
Intriguingly, we observed cell exit using organ transplan-
tation and two independent methods of egress detection: 
radioactively  labeled  nanoparticles  and  flow  cytometric 
staining  for  CD45.1/2  leukocyte  surface  markers.  Both 
methods indicated that between 5 and 13% of the cell popu-
lation departed from the site of inflammation within 24 h, a 
pathway of cell clearance outweighed by cell death. With 
both techniques, we found 10,000 exited cells in circulat-
ing blood. Liver, spleen, and lymph nodes were the dominant 
destination organs. Not surprisingly, the numbers of cells   
detected in these scavenging organs were somewhat higher   
when we used a nonbiodegradable label. The CD45.1/2 
leukocyte surface marker approach has previously revealed 
cell exit from transplanted, regressing atherosclerotic vascular 
beds in a setting of resolving chronic inflammation. These 
studies implied that certain lipids may inhibit cell migration 
(Llodrá et al., 2004). Future work must determine the bio-
logical relevance of cell exit beyond mere reduction of cell 
numbers in the inflammatory site. These observations might 
reflect a passive “spill over” phenomenon without conse-
quence. Alternatively, cell exit may be an active process that 
enables exchange of information through cell–cell contacts 
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v.8.5.2 (Tree Star, Inc.). For the detection of CLIO-VT750 (24 h after the 
injection of 15 mg of Fe/kg bodyweight), a filter configuration of 755/LP 
and 780/60 was used.
Analysis of proliferation with BrdU. For proliferation studies two time-
points were chosen for analysis: day 3 and 5 after MI. For stroke experi-
ments, we analyzed tissues on day 2 after injury. Mice were injected i.p. with 
1 mg BrdU (BD; Dolbeare et al., 1983) 12 and 24 h before analysis to allow 
incorporation into dividing cells. After tissue harvest, cells were processed 
and stained with anti–BrdU-APC against T cells (CD90-PE), B cells (B220-
PE), NK cells (CD49b-PE and NK1.1-PE), granulocytes (Ly-6G-PE), red 
blood cells (Ter-119-PE), myeloid cells (CD11b-APC-Cy7), DCs (CD11c-
Alexa Flour 700), M (F4/80-PE-Cy7), and Mo subsets (Ly-6C-FITC) 
according to the manufacturer’s protocol (BD).
Measurement of Mo/M exit by heart transplantation and flow   
cytometry. To investigate whether Mo leave the site of inflammation and, 
if so, in what amounts, we infarcted C57BL/6J (CD45.2+) and B6.SJL-Ptprca 
Pepcb/BoyJ  (CD45.1+)  mice  and  transplanted  the  infarcted  hearts  from 
CD45.2+ into CD45.1+ mice 3 d later. MI was induced in both donor and 
recipient to generate the same systemic immune environment of post-MI 
healing. 24 h after transplantation, mice were sacrificed, and their organs 
were harvested and processed for flow cytometric analysis as described above. 
Allelic labeling allowed the detection of donor-derived Mo that had de-
parted  the  transplanted  organ,  identified  as  CD11bhigh  (CD90/B220/
CD49b/NK1.1/Ly-6G)low (F4/80/CD11c)low Ly-6Chigh/low and CD45.2high. 
We normalized the cumulative number of retrieved donor-derived Mo in 
the recipient to the number of Mo found in the infarcted heart to calculate 
the percentage of exited Mo.
Adoptive transfers. MI was induced in CD45.1+ mice. For analysis of dis-
tribution and differentiation, 3 d later the mice were injected i.v. with 105 
GMP obtained by fluorescence-activated cell sorting (on FACSAria; BD) 
from the bone marrow of CD45.2+ mice that had undergone infarct surgery 
at the same time point as cell recipients. For comparison of WT versus   
IL-1R/ GMP transfer, cells were injected 1 d after MI. The multicolor 
antibody staining for GMP described above was also used for cell sorting, re-
sulting in cell population purity of >99.5%. 3 (experiment described in Fig. 
5 D) or 5 d (Fig. 10 D) after intravenous injection of CD45.2+ GMP, recipi-
ents were sacrificed and the transferred cells were fate-mapped by flow cyto-
metric analysis.
Measurement of cell exit using a Mo/M-targeted nanoparticle. 
One limitation of measuring cell exit by flow cytometric detection of the 
donor leukocyte antigen CD45.2 in the graft recipient’s potential target or-
gans is that the antigen might be scavenged rapidly, which renders it unde-
tectable. We therefore devised a labeling strategy using a nonbiodegradable, 
radioactive tag on iron-oxide nanoparticles (111In-CLIO) that target Mo/M 
(Nahrendorf et al., 2008). 111InCl3 (3.01 mCi, 114.7 MBq) was diluted   
with 20 µl ammonium acetate (0.4 M, pH 5.5) and added to CLIO-DTPA 
(250 µg) dissolved in 40 µl ammonium acetate (0.4 M, pH 5.5) and incu-
bated for 30 min at 75°C. After cooling to room temperature, the mixture 
was  purified  using  a  PD-10  column.  Fractions  containing  111In-CLIO-
DTPA were concentrated using microcentrifuge filters (MWCO = 50 kD). 
Concentrated 111In-CLIO-DTPA (2.71 mCi, 100.3 MBq; 87.4% RCY) was 
diluted with 1xPBS to a volume of 100 µl for injection. MI was induced in 
two mice. On day 2 after MI, mice were injected with 1.1 ± 0.1 mCi 111In-
CLIO-DTPA. On day 3 after MI and 24 h after injection of the nanoparti-
cle, hearts were explanted and their activity was measured by  counting 
(1480 Wizard 3”; PerkinElmer) while they were immersed in chilled buffer. 
After scintillation counting, hearts were immediately transplanted as de-
scribed above. Recipient mice were dissected 24 h later, and their organs 
were measured by  counting. Organ activity measurements were decay-
corrected to the time of transplantation. The decline in radioactivity of the 
grafted heart after 24 h residence in an uninjected recipient mouse reflected 
For  stroke  induction,  we  used  the  middle  cerebral  artery  occlusion 
model (Qiu et al., 2008). Animals were anesthetized with Isoflurane (2%/2 
liters O2). A silicone-coated 8–0 monofilament (Doccol Corporation) was 
introduced in the internal carotid artery and advanced to occlude the middle 
cerebral artery for 45 min. Regional cerebral blood flow was measured by 
laser-Doppler (ML191; AD Instruments Inc.) using a flexible probe, placed 
over the temporal bone after removal of part of the temporalis muscle, to 
confirm occlusion and reperfusion. Rectal temperature was maintained 
between 36.5°C and 37.5°C with a homeothermic blanket (Frederick Haer 
and Co.).
Female C57BL/6J (CD45.2+), B6.SJL-Ptprca Pepcb/BoyJ (CD45.1+) 
and B6.129S7-Il1r1tm1Imx/J (IL-1R/) mice were purchased from The 
Jackson Laboratory. All animal experiments were approved by Massachusetts 
General Hospital’s Institutional Review Committee.
Flow cytometry. To prepare single-cell suspensions from infarct tissue, 
hearts were harvested; minced with fine scissors; placed into a cocktail of 
collagenase I, collagenase XI, DNase I, and hyaluronidase (Sigma-Aldrich); 
and shaken at 37°C for 1 h. Cells were then triturated through nylon mesh 
and centrifuged (15 min, 500 g, 4°C).
Brain hemispheres were removed, triturated in HBSS with 15 mM 
Hepes and 0.5% glucose, and homogenized. Cells were then separated using 
a 70–30% Percoll solution.
Spleens were removed, triturated in HBSS (Mediatech, Inc.) at 4°C 
with the end of a 3-ml syringe, and filtered through nylon mesh (BD). The 
cell suspension was centrifuged at 300 g for 8 min at 4°C. Red blood cells 
were lysed with ACK lysis buffer, and the splenocytes were washed with 
HBSS and resuspended in HBSS supplemented with 0.2% (wt/vol) BSA and 
1% (wt/vol) flow cytometry. Peripheral blood was drawn via cardiac punc-
ture with citrate solution (100 mM Na-citrate, 130 mM glucose, pH 6.5) as 
anticoagulant, and red blood cells were lysed with ACK lysis buffer. Addi-
tionally, single-cell suspensions were obtained from liver and skeletal muscle 
by digestion with the cocktail described above. Single-cell suspension from 
lymph nodes was obtained by trituration in HBSS and filtering through   
nylon mesh.
Total viable cell numbers were determined from aliquots using a hema-
cytometer with Trypan blue (Mediatech, Inc.).
Cell suspensions were incubated in a cocktail of mAbs against T cells 
(CD90-PE), B cells (B220-PE), NK cells (CD49b-PE and NK1.1-PE), ery-
throid  cells  (Ter-119-PE),  granulocytes  (Ly-6G-PE),  myeloid  cells 
(CD11b-PE), dendritic cells (CD11c-PE), Mo subsets (Ly-6C-FITC), M 
(F4/80-PE-Cy7), antigen-presenting cells (I-Ab-APC), CD45.2-expressing 
cells (CD45.2-PerCP), CD45.1-expressing cells (CD45.1-APC), cells ex-
pressing IL-7 receptor  chain (IL-7RA-PE), c-kit+ cells (CD117-PE-Cy7), 
against Fc III/II receptor (CD16/CD32-APC-Cy7), Sca-1 (CD34-Alexa 
Flour 700), hematopoietic progenitor cells (CD34-FITC), and monoblasts 
(CD115-APC; all antibodies from BD or BioLegend). Cell cycle analysis 
was  performed  using  FxCycle  violet  stain  (Invitrogen).  Caspase-3-FITC   
(active form; BD) was used for staining of apoptotic cells. Mo/M were 
identified as CD11bhigh (CD90/B220/CD49b/NK1.1/Ly-6G)low Ly-6Chigh/low. 
Mo were identified as CD11bhigh (CD90/B220/CD49b/NK1.1/Ly-6G)low 
(F4/80/CD11c)lo  Ly-6Chigh/low.  M/dendritic  cells  were  identified  as 
CD11bhigh  (CD90/B220/CD49b/NK1.1/Ly-6G)low  (F4/80/CD11c)high 
Ly-6Clow. Neutrophils were identified as CD11bhigh (CD90/B220/CD49b/
NK1.1/Ly-6G)high  (F4/80/CD11c)low  Ly-6Cint.  Reported  cell  numbers 
were calculated as the product of total living cells (total viable leukocytes per 
ml) and percentage of cells within the Mo/M gate. Within this population, 
Mo subsets were identified as (F4/80/I-Ab/CD11c)low and either Ly-6Chigh 
or Ly-6Clow. Cell numbers were normalized for the weight of the infarct in 
milligrams, yielding the number of Mo per mg tissue. For transplant experi-
ments, cells were identified as described above and then plotted comparing 
CD45.2  vs.  CD45.1.  Within  the  (CD90/B220/CD49b/NK1.1/Ly-6G/
CD11b/CD11c)low  IL-7R–  Sca-1–  population,  MDPs  were  defined  as 
CD117int  CD115+,  whereas  GMPs  were  identified  as  CD117+  CD34+ 
CD16/32+. Data were acquired on an LSRII (BD) and analyzed with FlowJo JEM Vol. 209, No. 1 
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rotated, translated to match the image matrices, and finally fused. Fusion was 
done on a Macintosh computer with a quad-core processor, 16GB RAM, 
and an NVIDIA GeForce graphic card.
MRI. We performed in vivo MRI on days 1 and 21 after MI in mice with sple-
nectomy on the day of MI, splenectomy 3 d after MI and without splenectomy 
(n = 8–12 per group). A 7 Tesla horizontal bore Pharmascan (Bruker) and a 
custom-made mouse cardiac coil in birdcage design (Rapid Biomedical) were 
used to obtain cine images of the left ventricular short axis. We used ECG and 
respiratory gating using a gradient echo sequence (echo time 2.7 ms, 16 frames 
per RR interval; flip angle 30 degrees [or 60 degrees for delayed enhancement 
imaging]; in-plane resolution 200 × 200 µm; slice thickness 1 mm). The infarcted 
area was identified in end-diastolic frames as: (a) hypokinetic in cine-loops and 
(b) hyperenhancing after injection of gadolinium-diethylenetriaminepentaacetic 
acid (Berlex) at a dosage of 0.3 mmol/kg. Cardiac volumes and infarct size were 
quantitated from 6–8 short axis imaging slices covering the left ventricle, as de-
scribed previously (Leuschner et al., 2010; Panizzi et al., 2010).
Histology. Histology of hearts was assessed on days 3 and 6 after MI for im-
munofluorescence double staining with the TUNEL and CD11b. Hearts were 
excised, rinsed in PBS, and flash-frozen in O.C.T. compound (Sakura Finetek) 
with isopentane on dry ice. Fresh-frozen serial 5-µm thick sections were stained 
with the TUNEL reagents (DeadEnd Fluorometric TUNEL System, Promega) 
according to the manufacturer’s protocol, and then incubated with a rat anti–
mouse CD11b antibody (M1/70; BD), followed by a biotinylated secondary 
antibody. Streptavidin-Texas red (GE Healthcare) was used to detect the 
CD11b antibody, and the slides were coverslipped using a mounting medium 
with DAPI (Vector Laboratories) to identify cell nuclei. Images were captured 
and processed using an epifluorescence microscope, Nikon Eclipse 80i (Nikon 
Instruments Inc.), with a Cascade Model 512B camera (Roper Scientific).
For immunohistochemistry, heart histology was assessed on day 7 after 
MI. The tissue sections were stained for Mo (CD11b: M1/70; BD), M 
(MAC-3; BD), neovessels (CD31: PECAM-1; BD), and collagen deposition 
(Collagen I; Abcam). The appropriate biotinylated secondary antibodies, 
ABC kit (Vector Laboratories, Inc.) and AEC substrate (Dako) were used for 
color development, and all the sections were counterstained with Harris   
hematoxylin. For collagen analysis, Trichrome stains (MASSON; Sigma Al-
drich) and picrosirius red stains (Polysciences, Inc.) were performed accord-
ing to the manufacturers’ protocols, and the picrosirius red stained sections 
were analyzed using Nikon 50i (Nikon) equipped with a D-PP DIC rotat-
able polarizer (NBN74940). The positive area or cell numbers were quanti-
fied using IPLab (version 3.9.3; Scanalytics, Inc.) and analyzing five high 
power fields per section and per animal at magnification 200× or 400×.
Quantitative PCR. Total mRNA from heart tissue was isolated by QIA-
GEN RNeasy Mini kit. Oligo(dT)-based cDNA was generated by use of the 
SuperScript III First-Strand Synthesis kit (Invitrogen), which made cDNA 
only from the mRNA portion of the total RNA pool. Multiplex quantita-
tive PCR was performed on triplicate samples using Applied Biosystems 
TaqMan Assays. Infarct tissue was examined for expression of IL-1, IL-1, 
TNF, IL-6, CXCL12, VCAM-1, ICAM, M-CSF, GM-CSF, G-CSF, and 
appropriate controls (GAPDH). Gene expression was determined as x-fold 
difference after normalizing to GAPDH loading control.
Cytokine assay. Blood was drawn via cardiac puncture at the time of eu-
thanasia and allowed to clot at 37°C for 20 min. Serum was collected by 
centrifuging at 10,000 g for 5 min. Spleens were removed, homogenized, 
and centrifuged at 300 g for 8 min. Supernatants and serum samples were 
stored at 80°C until time of analysis. A mouse-specific ELISA kit (Quanti-
kine) for IL-1 was obtained from R&D Systems, and samples were pro-
cessed according to the manufacturer’s instructions.
Statistics. Results are expressed as mean ± SEM. Statistical comparisons 
between two groups were evaluated by Student’s t test and corrected by 
ANOVA for multiple comparisons. A value of P < 0.05 was considered to 
indicate statistical significance.
the nanoparticle’s departure from the organ and, because this nanoparticle 
distributes to Mo/M, by extension also the departure of these cells. The 
decay-corrected  activity  of  explanted  hearts  was  divided  by  the  average 
number of Mo present in the infarct, which yielded radioactivity per Mo. 
This number was then used to calculate the Mo cell content per organ in the 
transplant recipient by multiplying the photon counts measured in the 
respective organ with the activity per Mo.
Live cell imaging of Mo death. Splenic Mo were enriched by lineage 
depletion using MACS LD columns (Miltenyi Biotec) and PE–conjugated 
antibodies against B220, CD49b, NK1.1, Ly-6G, CD90, and Ter-119, 
followed by anti-PE magnetic beads (Miltenyi Biotec). The cells were then 
incubated with Annexin V-FITC (BD) antibodies and PI (BD). Imaging 
began after 30 min of incubation to allow primary antibody binding. The 
sample was prepared on a slide with coverslip and imaged at 37°C with 
an Olympus IX71 inverted fluorescence microscope customized with an 
X-Y-Z motion controller with stage assembly (Applied Precision) and a 
Photometrics HQ2 CCD camera (Photometrics). 10 field of views, each 
with 1–4 cells present, were imaged for 2 h, with 5-min intervals. Signal was 
plotted as a function of time, and the delay between onset of Annexin-V 
signal (early stage apoptosis) to PI (complete cell death) was analyzed in 
MATLAB (The Mathworks).
Tissue colony forming cell assay. To determine the number of myeloid 
colony-forming units in the spleen in the steady-state and after MI, a single-
cell suspension was prepared from the spleens of naive mice and those that 
had received coronary ligation 6 d before analysis. 3 × 105 splenocytes were 
plated in triplicates in complete methyl cellulose medium (MethoCult GF 
M3434; StemCell Technologies) according to the manufacturer’s instruc-
tions. Counts were performed after 10 d of culture in a humidified incubator 
at 37°C, 5% CO2. At least three independent samples per group were ana-
lyzed. Counts were normalized to the number of cells initially plated.
FMT-CT. For serial in vivo imaging, three groups of mice were investi-
gated: mice with MI (MI, no Spx), mice with MI and splenectomy on the 
same day (MI+Spx d0), and mice with MI and splenectomy on day 3 after 
MI (MI+Spx d3; n = 8–12 per group). On day 5 after MI, we performed 
FMT-CT imaging (Nahrendorf et al., 2009b; Panizzi et al., 2010) to inter-
rogate  the  magnitude  of  inflammation.  Using  three-channel  acquisition   
allowed simultaneous analysis of phagocytic activity (CLIO-VT680), pro-
teolytic activity (Prosense-750; PerkinElmer) and angiogenesis (Integrisense-
800). Data were acquired 24 h after injection of 15 mg/kg of CLIO-VT680, 
5 nmol of the pan-cathepsin protease sensor Prosense-750 and 5 nmol of the 
integrin binding sensor Integrisense-800. A 3D FMT dataset was recon-
structed in which fluorescence per voxel was expressed in nM. To robustly 
identify the region of interest in the heart, anatomical imaging with CT pre-
ceded FMT. The imaging cartridge containing the anesthetized mouse was 
placed into the Plexiglas holder that supplied Isoflurane, warm air, and opti-
mal positioning in the CT (Inveon PET-CT; Siemens). The CT x-ray 
source operated at 80 kVp and 500 A with an exposure time of 420 ms. 
The effective 3D resolution was 80 µm isotropic. Isovue-370 was infused 
intravenously at 40 µl/min through a tail vein catheter. The CT reconstruc-
tion protocol performed bilinear interpolation, used a Shepp-Logan filter 
and scaled pixels to Hounsfield units.
Image fusion of FMT with CT realized three-dimensional mapping of 
fluorescence within the anatomical reference CT. The approach was based 
on a multimodality-compatible animal holding device that provides fiducial 
landmarks on its frame (Nahrendorf et al., 2010a). The imaging cartridge 
lightly compressed the anesthetized mouse between optically translucent 
windows and thereby prevented motion during transfer between modalities. 
The three-dimensional distribution of the fiducials enabled automated co-
registration of datasets. The point based co-registration tool kit in OsiriX 
shareware (64 bit, version 3.5.1) fused images after identification of fiducials 
in respective modalities. Fiducials were tagged with point markers to define 
their XYZ coordinates. Using these coordinates, data were resampled, 136 Monocyte kinetics in acute inflammation | Leuschner et al.
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